$23.12
0.62.66%
Pre-Market: 4:32 AM EDT
15 minutes delayed
Comments
Loading...
Intellia Therapeutics (NTLA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestIntellia Therapeutics (NASDAQ:NTLA) Stock Quotes, Forecast and News Summary
Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 504.00 / 1.50M |
| Day Range | - - - |
| 52 Wk Range | 19.21 - 35.88 |
| Market Cap | $2.35B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 15.37% |
| Days to Cover | 14.02 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Intellia Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based ther...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intellia Therapeutics (NTLA) stock?
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Who are Intellia Therapeutics (NTLA) competitors?
Other companies in Intellia Therapeutics’s space includes: SpringWorks Therapeutics (NASDAQ:SWTX), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO), Arrowhead Pharma (NASDAQ:ARWR) and ACADIA Pharmaceuticals (NASDAQ:ACAD).
What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?
Intellia Therapeutics has a consensus price target of $81.36.
What is the current price for Intellia Therapeutics (NTLA)?
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $23.12 last updated September 19, 2024 at 4:32 AM EDT.
Does Intellia Therapeutics (NTLA) pay a dividend?
There are no upcoming dividends for Intellia Therapeutics.
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Intellia Therapeutics (NTLA) going to split?
There is no upcoming split for Intellia Therapeutics.
What sector and industry does Intellia Therapeutics (NTLA) operate in?
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.